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Many features of the chaperone action of clusterin are similar to those of the intracellular small heat
shock proteins (sHSPs) which, like clusterin, exist in solution as heterogeneous aggregates. Increased
temperature induces dissociation of some sHSP aggregates and an enhanced chaperone action,
suggesting that a dissociated form is the active chaperone species. We recently reported that clusterin
aggregates dissociate at mildly acidic pH. To further explore the similarities between clusterin and the
sHSPs, we tested the effects of temperature and pH on the structure of clusterin and its chaperone
action. Our results demonstrate that increased temperature does not induce dissociation of clusterin
aggregates, or other major structural changes, and has little effect on its chaperone action. However, we
show that the chaperone action of clusterin is enhanced at mildly acidic pH. Clusterin is the first
chaperone shown to be activated by reduced pH. This unique mode of activation appears to result from
an increase in regions of solventexposed hydrophobicity which is independent of any major changes in
secondary or tertiary structure. We propose a model in which low pH-induced dissociation of clusterin
aggregates increases the abundance of the heterodimeric chaperone-active species, which has greater
hydrophobicity exposed to solution.
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SUMMARY
Many features of the chaperone action of clusterin are similar to those of the intracellular
small heat shock proteins (sHSPs) which, like clusterin, exist in solution as
heterogeneous aggregates. Increased temperature induces dissociation of some sHSP
aggregates and an enhanced chaperone action, suggesting that a dissociated form is the
active chaperone species. We recently reported that clusterin aggregates dissociate at
mildly acidic pH. To further explore the similarities between clusterin and the sHSPs, we
tested the effects of temperature and pH on the structure of clusterin and its chaperone
action. Our results demonstrate that increased temperature does not induce dissociation of
clusterin aggregates, or other major structural changes, and has little effect on its
chaperone action. However, we show that the chaperone action of clusterin is enhanced at
mildly acidic pH. Clusterin is the first chaperone shown to be activated by reduced pH.
This unique mode of activation appears to result from an increase in regions of solventexposed hydrophobicity which is independent of any major changes in secondary or
tertiary structure. We propose a model in which low pH-induced dissociation of clusterin
aggregates increases the abundance of the heterodimeric chaperone-active species, which
has greater hydrophobicity exposed to solution.
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Clusterin is a heterodimer of disulfide-linked polypeptide chains which bear N-linked
carbohydrates comprising about 30% of the total mass of the molecule. Although it
migrates at about 70-80 kDa on SDS/PAGE, mass spectrometry analyses have shown that
the human serum form of clusterin comprises two major glycoforms, one of 58.5 kDa and
the other of 63.5 kDa (1). Clusterin is normally secreted from mammalian cells and is
both widely distributed and highly conserved; between different mammals, about 70-80%
of the amino acid sequence of clusterin is identical (2). Clusterin expression is increased
during pathological stresses (eg hydrostatic pressure insult or ischemic injury in the
kidney) and certain disease states (eg gliomas) (3). A variety of independent studies have
suggested that clusterin protects cells from stresses such as TNFα, heat and oxidative
stress (2). Furthermore, recent studies of clusterin knock-out mice have indicated that
clusterin protects mice from (i) the pathological consequences of inflammation associated
with experimentally-induced autoimmune myocarditis (4) and ischemia (5), although the
latter claim has been disputed (6), and (ii) age-dependent deposition of antibodycontaining aggregates in the kidney (7). The clusterin promoter contains a highly
conserved 14 bp element which is recognized by the transcriptional regulator heat shock
factor 1 (HSF1) (8). HSF1 activates expression of heat shock proteins (which protect
cells from stresses) and clusterin (8). An emerging theme is that clusterin is a protective
molecule which is upregulated during times of physiological stress.

We recently demonstrated that clusterin is a molecular chaperone which potently inhibits
the stress-induced precipitation of many different proteins in vitro (9,10). When present
at physiological concentrations in undiluted human serum, clusterin is able to inhibit
protein precipitation induced by heat or reduction (10). Thus, the chaperone action of
clusterin might be physiologically “protective” by reducing the rate or extent of
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progression of diseases associated with abnormally high levels of protein precipitation.
The recent demonstration that aging clusterin knock-out mice develop insoluble protein
deposits containing antibody (7) suggests that clusterin may inhibit antibody aggregation
and precipitation in vivo. Furthermore, by complexing with partly unfolded proteins or
other hydrophobic molecules at sites of inflammation, clusterin might solubilize these
molecules and facilitate their recycling or disposal, in either case contributing towards
resolution of inflammation.

Many features of the chaperone action of clusterin are similar to that of the intracellular
small heat shock proteins (sHSPs). For example, both types of chaperone interact
specifically with stressed proteins that are slowly aggregating on the off-folding pathway
towards a precipitated state (11) to form stable, solubilized high molecular weight
complexes (2,9). They do not themselves refold stressed proteins but by binding to them
create a refolding-competent reservoir from which other ATP-dependent chaperones may
retrieve functional proteins (10). The quaternary structure and chaperone action of at least
some of the sHSPs is affected by increased temperature. For example, elevated
temperature induces an increased rate of subunit exchange in mammalian αA-crystallin
and a concomitant enhancement of its chaperone action (12). Similarly, at low to
physiological temperatures, yeast HSP26 exists in solution as oligomers. However,
elevated temperature induces partial dissociation of these oligomers and an enhancement
of the chaperone activity of the protein, implying that a non-aggregated, possibly dimeric
form of HSP26 is responsible for its chaperone action (13).

The heterodimer form of clusterin is known to reversibly aggregate; this process is pHdependent with dissociation of the aggregates being favored at mildly acidic pH (14).
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This transition is associated with increased binding of clusterin to its native ligands,
heparin (15), immunoglobulins, glutathione-S-transferase and polymeric C9 (14).
However, these studies did not show whether low pH induces any changes in the
chaperone activity of clusterin concomitant with dissociation of its aggregated forms nor
whether the aggregation state and chaperone activities of clusterin were temperaturedependent. Therefore, we tested whether elevated temperature had any effects on the
aggregation state or chaperone action of clusterin. In light of our recent results (14,15),
we also tested whether low pH affected the chaperone action of clusterin in vitro. In
addition, we used circular dichroism spectroscopy to investigate structural changes
induced in clusterin by changes in temperature and pH, and binding studies with 4,4’bis(1-anilino-8-naphthalene

sulfonate)

(bis-ANS)

to

test

whether

hydrophobic

interactions were important in the chaperone action of clusterin. The results demonstrate
that, unlike the sHSPs, increased temperature does not induce dissociation of aggregated
forms of clusterin or major changes in its secondary or tertiary structure and gave only a
minor increase in the efficiency of its chaperone action. In contrast, the results show that
(i) mildly acidic pH enhances the ability of clusterin to bind to stressed proteins and to
inhibit their precipitation, (ii) this transition is accomplished with little measurable
changes in the secondary or tertiary structure of clusterin but is accompanied by an
increase in regions of solvent-exposed clusterin hydrophobicity, and (iii) the exposed
regions of hydrophobicity on clusterin probably (at least partly) mediate its interactions
with stressed proteins.
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EXPERIMENTAL PROCEDURES

Materials.

Alcohol

dehydrogenase

(ADH),

α-lactalbumin,

4,4’-bis(1-anilino-8-

naphthalene sulfonate) (bis-ANS), bovine serum albumin (BSA), catalase, casein, insulin,
iodoacetamide, o-phenylenediamine dihydrochloride (OPD), and ovotransferrin were all
obtained from Sigma (St. Louis, MO, USA). Dithiothreitol (DTT) was obtained from
Boehringer Mannheim (Sydney, Australia). All buffer salts and H2O2 were obtained from
Ajax Chemical Co. (Sydney, Australia). Clusterin was purified from human serum
(obtained from the Red Cross Blood Bank, Sydney, Australia) by immunoaffinity
chromatography as previously described (16). Glutathione-S-transferase (GST) was
prepared by thrombin cleavage of GST-fusion proteins as described (17). α-Crystallin
was purified from bovine lenses as previously described (18).

Circular Dichroism Analyses. A Jasco J-720 spectropolarimeter, linked to a Neslab
RTE-111 cooling system, was used to acquire circular dichroism data. Far-UV (195-260
nm) CD studies were performed using a 1 mm cell with clusterin at 200 µg/ml in 10 mM
sodium phosphate, pH 7.4. Spectra were acquired at 50 mdeg sensitivity with a step
resolution of 0.5 nm and a bandwidth of 1 nm. Estimates of the percentages of α-helical,
β-sheet, β-turn and unordered secondary structure were made by deconvolution of these
data using the programs CDSSTR (19) and CONTIN-LL (20). The means of the values
calculated using these two programs are presented in Figure 1B. Near-UV (260-320 nm)
spectra were obtained using a 1 cm cell with clusterin at 1.2-1.4 mg/ml in either 20 mM
sodium phosphate, pH 7.4 or 20 mM MES, pH 5.5. Spectra were acquired at 10 mdeg
sensitivity with resolution and bandwidth both 0.2 nm. The data shown are mean residue
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ellipticities ([θ]MRE), calculated from an average of three scans, using values of 6.1 x 104
g/mol for the average molecular weight of serum clusterin (1) and 117 for its mean
residue weight.

Measurements of bisANS Fluorescence. All fluorometric analyses were performed using
an LS 50B luminometer controlled by FL Winlab software (Perkin-Elmer). All samples
were degassed and filtered through 0.45 µm filters (Millipore, Sydney, Australia) prior to
analysis. Clusterin (100 µg/ml) in PBS containing 10 µM bisANS was incubated at
temperatures between 25 and 60 oC and the fluorescence of bis-ANS at 480 nm (5 nm
bandwidth) was measured with an excitation wavelength of 385 nm (5 nm bandwidth).
Control samples contained 40% (v/v) ethanol instead of clusterin.

Photochemical labelling of clusterin with bisANS. This was done using the method of
(21). Clusterin (0.8 mg/ml) was mixed with 100 µM bisANS in PBS and allowed to
incubate at 25 ºC for 20 min. Excess bisANS was removed by dialysis against PBS. The
sample was then placed in a 3.5 cm Petri dish and illuminated at 254 nm for 20 min using
a UV lamp, placed approximately 2 cm above the sample. Control samples were treated
similarly, except that they did not receive bisANS. Covalent labelling of the clusterin
with bisANS was confirmed by SDS/PAGE of aliquots of these samples; a fluorescent
band corresponding to the migration position of clusterin was observed (results not
shown). A bisANS:clusterin molar ratio of 7:1 was calculated from absorbance
measurements, assuming an extinction coefficient for bisANS at 385 nm of 16.7 mM1

cm-1.
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ELISA. (A) Temperature and pH Dependence of the Binding of Clusterin to Stressed
Proteins. GST and ovotransferrin, at 20 µg/ml in 50 mM Na2HPO4, pH 7.0 were
adsorbed onto ELISA plates (Sarstedt Australia, Adelaide, Australia) by incubating at 37
°C (non-stress) or 60 °C (stress) for 1 h. BSA (1 mg/ml) was adsorbed onto ELISA plates
by incubation in the same buffer for 5 h in the presence or absence of 20 mM DTT. The
plates were then blocked with 1% (w/v) heat-denatured casein (HDC) prepared in PBS.
To exclude any possible formation of disulfide bonds between clusterin and BSA, DTTtreated BSA was then incubated with 5 mM iodoacetamide at 37 °C for 1 h. Clusterin,
initially at 10 µg/ml in 50 mM Na2HPO4, pH 7.0, was then serially diluted in the same
buffer in binary steps down each ELISA plate and incubated for 1 h at 37 oC (or other
temperature as indicated). In other experiments, the procedure was the same, except that
the 50 mM Na2HPO4 buffer was adjusted to pH 6.0-7.5; in some cases, instead of purified
clusterin, normal human serum (initially undiluted, adjusted to pH 6.0-7.5) was applied to
the plate and serially diluted in buffer of corresponding pH. An equi-volume mixture of
hybridoma culture supernatants containing G7, 41D and 78E anti-clusterin monoclonal
antibodies was used to detect bound clusterin (9). Bound primary antibodies were
detected with sheep anti-mouse Ig-HRP (Silenus, Sydney, Australia) using ophenylenediamine dihydrochloride (OPD; 2.5 mg/ml in 0.05 M citric acid, 0.1 M
Na2HPO4, pH 5.0, containing 0.03% (v/v) H2O2) as substrate. (B) Inhibition of the
Binding of Clusterin to Stressed Proteins by bisANS. Insulin (100 µg/ml) and lysozyme
(20 µg/ml) in 0.1 M NaHCO3, pH 9.5 were adsorbed to ELISA plates for 1 h at 37 °C.
The plates were then incubated in the presence of 25 mM DTT in PBS for 1 h at 37 °C
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and then 10 mM IAA in PBS for 30 min at 37 °C. Alcohol dehydrogenase (20 µg/ml in
0.1 M NaHCO3, pH 9.5) was adsorbed to ELISA plates for 1 h at 60 °C. In all cases the
plates were then blocked with 10 mg/ml BSA in 10 mM NaH2PO4, 10 mM MES, 0.15 M
NaCl, pH 6 (PBS/MES/BSA). In some experiments, stressed lysozyme adsorbed to
ELISA wells was incubated with 0-100 µM bisANS in PBS/MES/BSA for 1 h at 37 ºC
before the binding of clusterin to it was measured. PBS/MES/BSA containing clusterin
(10 µg/ml) and bisANS (at concentrations indicated in the Figure Legends) was then
added to the wells and incubated for 1 h at 37 °C. Subsequently, bound clusterin was
detected using undiluted tissue culture supernatant from G7 hybridoma cells and, finally,
sheep anti-mouse Ig-HRP and OPD substrate as described above.

Protein Precipitation Assays. The effects of clusterin on stress-induced precipitation of
target proteins was monitored by measuring, using an automated diode-array
spectrophotometer (Hewlett-Packard GMBH, Germany), the turbidity associated with
target protein precipitation as absorbance at 360 nm. In some experiments, the effects of
different temperatures on the extent of DTT-induced protein precipitation in the presence
and absence of clusterin was tested. Solutions of BSA (750 µg/ml), or a mixture of BSA
(750 µg/ml) with clusterin (at 300 µg/ml), were prepared in 50 mM Na2HPO4, pH 7.0
containing 20 mM DTT. These solutions were then incubated at 37 oC or 50 oC and
turbidity measured every 15 min for 2.5-5 h. In one set of experiments, individual
solutions of GST (250 µg/ml) or mixtures of GST (at the same final concentration) with
100 µg/ml of either unmodified clusterin or bisANS-modified clusterin (made as
described above) in PBS were heated at 60 oC and turbidity measured as described every
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30 s for 20 min. In other experiments, the extent of protein precipitation at pH 7.5 was
compared to that at lower pH values, in the presence and absence of clusterin or the sHSP
α-crystallin.

Individual solutions of ovotransferrin (2 mg/ml) or mixtures of

ovotransferrin at the same final concentration with clusterin (at 75 µg/ml) were prepared
in 50 mM Na2HPO4 (pH 6.0, 6.5 or 7.5) and heated at 60 °C. Related experiments were
performed identically, except that ovotransferrin was used at 1 mg/ml and α-crystallin
(0.65 mg/ml) was used instead of clusterin. Measurements of turbidity were taken every 1
min for a total of 30 min and were performed as described above. Lastly, normal human
serum (NHS) or clusterin-depleted human serum (CDS; prepared by immunoaffinity
chromatography), were diluted 1 in 10 in 50 mM Na2HPO4 (pH 6.0-7.5), heated at 60 oC,
and measurements of turbidity taken as previously described.

Quantitative Data Analysis and Plotting. Kaleidagraph Version 3.51 (Synergy Software,
Reading, PA, USA) was used for quantitative data analysis and plotting. The CD spectra
shown were subjected to Stineman smoothing, which reduces the noise without
perturbing the appearance of the data (22). Apparent inhibition constants for the
inhibition of binding of clusterin to stressed proteins by bisANS were obtained by nonlinear regression analysis of equation (1) onto the data:
Bmax
B

=

1 + [bisANS]/Ki

(1)

where Bmax and Ki represent the ELISA signal in the absence of bisANS and the
apparent inhibition constant, respectively, and B is the measured ELISA signal. Statistical
comparisons between different apparent inhibition constants were made using Student’s
t-test; t-values with p < 0.05 were considered significant.
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RESULTS

Effects of Temperature on the CD Spectra of Clusterin. In order to assess the extent to
which the overall secondary structure of clusterin changes with increasing temperature,
we measured the far UV circular dichroism spectra of clusterin over the temperature
range 25-85 oC. The results of calculation of the secondary structural content of clusterin
from these data are shown in Figure 1A. These analyses showed that, as clusterin was
heated from 25 ºC to 85 ºC, its calculated α-helical content decreased from about 62% to
about 35%, with a concomitant increase in calculated disordered structure from about
17% to about 28% and smaller increases in calculated β-sheet and β-turn content. The
midpoint for these changes was about 55 oC. These results indicate that there was
progressive loss of secondary structure in clusterin over this temperature range. Upon
cooling these changes were largely reversible, with recovery of calculated α-helical
content to 57% and disordered structure to 21% (Figure 1A). It is worth noting that
clusterin retains significant secondary structure even at elevated temperatures because a
minimum in the spectra at about 200 nm, characteristic of disordered structure, was not
observed at any temperature tested (data not shown). Similar analyses of near-UV CD
spectra for clusterin indicated that there was also a progressive loss of tertiary structure as
the temperature increased from 24 oC to 56 oC but that the changes induced at 56 oC were
only partly reversible (data not shown).

Effects of Temperature on the Extent of Exposed Clusterin Hydrophobicity. We
assessed whether there were temperature-dependent changes in the level of exposed
hydrophobic regions on clusterin by measuring the fluorescence of bisANS bound to
clusterin at different temperatures. bisANS is a polarity-sensitive probe which has been
11

used to monitor changes in exposed hydrophobic regions in sHSPs (23,24). There was a
progressive decrease in the fluorescence of bisANS bound to clusterin with temperature
over the range 20 – 50 oC (Figure 1B). This change was reversible because there was
overlap of the heating and cooling traces (Figure 1B, compare open and closed squares).
A number of factors could contribute to this decrease: changed collisional quenching,
increased non-radiative decay and temperature-dependent changes in exposed
hydrophobic regions on clusterin. To assess the relative contributions of these, we also
measured the temperature-dependence of the fluorescence of bisANS in 40% ethanol (the
relative quantum yield and emission maxima of bisANS in this solvent were similar to
those of bisANS bound to clusterin). The fluorescence of bisANS in 40% ethanol also
decreased with temperature over the range 20 – 50 oC and this change was also reversible
(Figure 1B, compare open and closed circles); this decrease can be attributed to the
combined effects of changes in the collisional quenching and non-radiative decay of the
excited state of bisANS with temperature. However, the finding that the decrease in the
fluorescence of bisANS bound to clusterin over this temperature range was greater than
the decrease in the fluorescence of bisANS in 40% ethanol suggests that there is a
decrease in the extent of exposed hydrophobicity on clusterin with increasing
temperature.

Effects of Temperature on the Aggregation State of Clusterin. When clusterin was
analyzed by size exclusion chromatography at either 37 oC or 50 oC, there were no
significant differences in the distribution of molecular species fractionated (data not
shown). This indicates that variation in temperature over the range 37-50 ºC had little
effect on the distribution of clusterin between its 80 kDa heterodimeric form and larger
oligomeric species.

12

Effects of Temperature on Interactions of Clusterin With Stressed Proteins. In ELISA,
the binding of clusterin to stressed BSA was only slightly enhanced when the temperature
was increased above 37 oC (Figure 2). Similar results were obtained in other ELISAs,
which indicated that the binding of clusterin to stressed GST or lysozyme was also only
marginally affected by increased temperature (data not shown). Furthermore, temperature
had only a small effect on the ability of clusterin to inhibit stress-induced protein
precipitation. In the absence of clusterin, precipitation of BSA induced by reduction was
more rapid at 50 oC than at 37 oC but the final level of precipitation obtained in the
absence of clusterin was similar at both temperatures (Figure 3). At 50 oC, at the end of
the time course (300 min), clusterin had decreased precipitation of BSA to a level about
13.5% less than that achieved at 37 oC (Figure 3). Similar results were obtained testing
the effects of increased temperature on the ability of clusterin to inhibit the reductive
stress-induced precipitation of α-lactalbumin, lysozyme and insulin (data not shown).
Small effects of temperature on the chaperone action of clusterin were also confirmed in
similar experiments comparing the ability of clusterin to inhibit precipitation of stressed
proteins at 37 oC and 42 oC (data not shown). Collectively, the results indicate that (i) an
increase in temperature from 37 oC to 50 oC causes only a small increase in the ability of
clusterin to bind to stressed proteins and to inhibit their precipitation from solution, and
(ii) the structural changes induced in clusterin by heating have only a limited effect on its
binding to stressed protein.

Effects of Low pH on the Structure of Clusterin.
We previously demonstrated that reduction of pH from 7.4 to 5.5 induced in clusterin (i)
no apparent changes in the predicted contents of α-helical, β-sheet and β-turn regions
(detected by far-UV CD spectroscopy), (ii) significant dissociation of clusterin oligomers
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to form the 80 kDa clusterin heterodimer (detected by size exclusion chromatography),
and (iii) an increase in the exposed hydrophobic surface (detected by measurements of
bis-ANS fluorescence) (14). To further examine the effects of mildly acidic pH on
clusterin structure, we measured near-UV CD spectra for clusterin at pH 7.5 and pH 5.5.
The results show that reducing the pH from 7.4 to 5.5 did not induce any major changes
in the broad negative amplitude peak in [θ]MRE in the near-UV region (Figure 4). This
suggests that mildly acidic pH does not cause major changes in the tertiary structure of
those regions of clusterin containing its aromatic residues.

Effects of Low pH on Interactions of Clusterin with Stressed Proteins. In ELISA,
purified clusterin bound most strongly to all three stressed proteins at pH 6.0, with
progressively less binding detected at pH 6.5 and 7.5 (Figures 5A-C). Similarly,
enhanced binding of purified clusterin at mildly acidic pH was observed when insulin,
alcohol dehydrogenase and lysozyme were used as target proteins (data not shown). This
trend was the same, regardless of whether the target protein was stressed by heat or
reduction. Increased binding at reduced pH was also obtained in ELISA experiments in
which clusterin, present in pH-adjusted unfractionated human serum, bound to stressed
GST (Figure 5D) or ovotransferrin or lysozyme (data not shown) adsorbed to ELISA
wells. The increase in binding of clusterin to stressed proteins at low pH was greater for
purified clusterin than for clusterin in human serum (compare Figures 5A-C to Figure
5D). This may result from some serum protein(s), partly unfolded at pH 6, competing
with plate-bound stressed protein for clusterin binding. The level of binding of purified
clusterin to stressed proteins at pH 5.0 and 4.0 was comparable to that obtained at pH 6.0
(data not shown). In control experiments, we verified that incubating stressed proteins

14

coated onto ELISA wells with any of the different pH buffers used did not affect the
amount of stressed protein bound to the wells (data not shown).

In heat-induced protein precipitation assays, in the absence of clusterin, changes in pH
between 7.5 and 6.0 had little effect on the time course or extent of precipitation of
purified ovotransferrin in solution (Figure 6A) or proteins in unfractionated human serum
(Figure 6B). In contrast, the extent of protein precipitation in the presence of clusterin
was significantly reduced at lower pH, both for purified proteins and unfractionated
human serum. Under the conditions tested, the ability of clusterin to inhibit stressinduced precipitation of ovotransferrin was least at pH 7.5 (approximately 33%
inhibition), increased at pH 6.5 (approximately 71% inhibition) and was greatest at pH
6.0 (approximately 97% inhibition) (Figure 6A). Similar results were obtained using
catalase and GST as stressed protein targets (data not shown). The corresponding levels
of clusterin-mediated inhibition of protein precipitation in unfractionated human serum
were 53% at pH 7.5 and 83% at pH 6.0 (Figure 6A). Further decreasing the pH to 5.0 and
4.0 only marginally increased the ability of clusterin to inhibit heat-induced precipitation
of proteins (data not shown). Thus, at mildly acidic pH, clusterin binds more strongly to
stressed proteins and is more efficient at inhibiting their precipitation from solution. To
the best of our knowledge, the effects of mildly acidic pH on the action of other
chaperones has not previously been reported. Our results demonstrate that the ability of
the cytosolic sHSP α-crystallin to inhibit heat-induced precipitation of ovotransferrin
decreases as the pH is changed from pH 7.5 to 7.0, and undergoes further more
substantial decreases as the pH is dropped to pH 6.5 and then 6.0 (Figure 6B). Similar
results were obtained when catalase was used as a stressed protein target (data not
shown). Thus, in stark contrast to the effects of mildly acidic pH on clusterin, the
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chaperone activity of α-crystallin is progressively reduced as the pH is decreased below
that normally found in cytosol.

bisANS Inhibits the Interaction of Clusterin with Stressed Proteins. We have
previously shown that extra hydrophobic surfaces, detected using bisANS, are exposed
on clusterin at mildly acidic pH (14). We hypothesized that these region(s) may provide
additional site(s) for binding of clusterin to stressed proteins. We tested this hypothesis
by examining the effects of bisANS on the binding of clusterin to stressed proteins in
ELISA under mildly acidic conditions. The results of this showed that, at pH 6.0, bisANS
gave dose-dependent inhibition of the binding of clusterin to stressed lysozyme, insulin
and alcohol dehydrogenase (Figure 7A). At a concentration of 50-100 µM, bisANS gave
near-complete inhibition of binding in all cases. These data indicate that hydrophobic
interactions predominate in the binding of clusterin to stressed proteins. Non-linear
regression analysis of equation (1) onto these data gave apparent inhibition constants for
bisANS of 7.5 ± 2.6 µM, 10.6 ± 2.6 µM and 12.6 ± 2.0 µM for stressed lysozyme,
insulin, and alcohol dehydrogenase, respectively. T-test analyses showed that there was
no significant difference between any of these values. In addition, we showed that,
relative to unmodified clusterin, clusterin which had been photochemically labeled with
bisANS showed an impaired ability to prevent stress-induced precipitation of both GST
(Figure 7B) and alcohol dehydrogenase (data not shown).
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DISCUSSION

One of the similarities between clusterin and the mammalian sHSPs is that both exist in
solution as heterogeneous aggregates of high molecular mass (14, 25). The sHSPs
undergo structural alterations with increasing temperature, leading to the exposure of
hydrophobic sites which are then available to bind to target proteins (12,13,25,26).
Furthermore, at higher temperatures, sHSPs show increased subunit exchange and
enhanced chaperone ability. This has led to a model in which temperature-induced
dissociation of sHSP aggregates yields a chaperone-active species in which the
hydrophobic surfaces previously located at the interfaces between the subunits of the
aggregate are now available to bind to target proteins (13,26,27). In contrast, the
distribution of clusterin between different aggregated forms is independent of
temperature over the range 37–50 ºC (data not shown). Moreover, the ability of clusterin
to bind to stressed proteins in ELISA (Figure 2) and its capacity to prevent the
precipitation of these proteins (Figure 3) also show little variation over this temperature
range.

Despite the above, far-UV (Figure 1A) and near UV (data not shown) CD spectra showed
that clusterin undergoes a progressive and incompletely reversible loss of secondary and
tertiary structure with increasing temperature, with a transition at about 50 oC. In
addition, the finding that the fluorescence of bisANS bound to clusterin decreased to a
greater extent with temperature than did the fluorescence of bisANS in 40% ethanol
(Figure 1B) suggests that there is a decrease in exposed hydrophobic regions on clusterin
with increasing temperature. How can these data be reconciled with the finding that
increased temperature has little effect on the chaperone action of clusterin? One inherent
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limitation of CD and fluorescence measurements is that they do not identify the specific
locations of induced structural changes in a protein molecule, rather, they only provide
overall structural information. Therefore, it is possible that the structural changes
detected in the experiments represented in Figure 1 do not affect the target proteinbinding region(s) in clusterin. Accepting this hypothesis, the observations that (i)
quantitative analysis of the far-UV CD data (Figure 1A) showed that there was an
appreciable loss of α-helical content of clusterin at 50 oC compared to 37 oC, and (ii) the
chaperone action of clusterin was largely unaffected at 50 ºC compared to 37 ºC (Figures
2 and 3), imply that the temperature-sensitive α-helical regions do not contribute to the
binding site(s) on clusterin for stressed proteins. Furthermore, since there is no change in
the aggregation state of clusterin with increasing temperature, we can deduce that the
hydrophobic regions of clusterin that become less exposed to solution at elevated
temperatures are probably discrete from those regions that associate during clusterin
aggregation and that may form parts of the target protein-binding site(s).

We have previously shown that the aggregation state of clusterin is sensitive to pH, with
the 80 kDa form being favored at mildly acidic pH. This was correlated with increased
exposure of hydrophobic regions on clusterin (probed by bisANS fluorescence) and
increased binding of clusterin to native protein and polysaccharide ligands but very little,
if any, change in overall secondary structure (14,15). Here we show that mildly acidic pH
has little effect on the environment of the aromatic residues of clusterin (probed by nearUV CD; Figure 4) but that these conditions induce a substantial increase in the ability of
clusterin to bind to stressed proteins and to prevent their precipitation (Figures 5 and 6).
The pH-dependent enhancement of the chaperone action of clusterin did not appear to
reflect the effects of pH on the target proteins because, using the same target proteins,
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there was a progressive decrease in the chaperone activity of α-crystallin with reducing
pH (Figure 6B). This indicates that mildly acidic pH is probably directly affecting
clusterin to enhance its chaperone activity.

The ability of bisANS to inhibit the interaction between clusterin and stressed proteins
(Figure 7A) could be explained by it binding to exposed hydrophobic regions on either or
both binding partners. If the binding of bisANS was predominantly to the stressed
protein, it is likely that different Ki values would be obtained for the different targets (eg,
bisANS binds to tubulin with about 20-fold higher affinity than to stromelysin-1 (28,29),
particularly considering the large difference in size and structure of insulin (5.8 kDa),
lysozyme (14 kDa) and alcohol dehydrogenase (147 kDa). Thus, the fact that the
apparent inhibition constants for bisANS were (within experimental error) the same
suggests that its interaction with clusterin, rather than the stressed proteins, was primarily
responsible for the inhibition of binding. The hypothesis that hydrophobic regions of
clusterin are important in its chaperone action is further supported by our demonstration
that photochemical cross-linking of bisANS to clusterin reduces its ability to inhibit the
precipitation of stressed proteins (Figure 7B). bisANS has been similarly used to label
hydrophobic regions important in the action of other chaperones (30). Thus, while we
cannot exclude the possibility that bisANS-mediated inhibition of clusterin binding to
stressed proteins may be partly due to bisANS binding to hydrophobic regions on
stressed proteins, the results strongly suggest that (i) a large component of the bisANS
inhibitory effect is due to its binding, in each case, to the same region(s) of exposed
hydrophobicity on clusterin, and (ii) these regions are important in the chaperone action
of clusterin.
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Collectively, our results indicate that dissociation of clusterin aggregates is favored at
mildly acidic pH and, despite no major changes in overall secondary or tertiary structure
detected by CD spectroscopy, more hydrophobic surfaces are exposed to solution under
these conditions. These surfaces are probably responsible for the enhanced ability of
clusterin to bind to stressed proteins and to inhibit their precipitation at mildly acidic pH.
The response of clusterin to mildly acidic pH is thus strikingly similar to that of the
sHSPs to increased temperature. By analogy with the sHSPs, we propose that at
physiological pH, hydrophobic chaperone binding surfaces on clusterin are buried in
interfaces between the 80 kDa heterodimers in the aggregated forms of the protein.
However, at mildly acidic pH, the equilibrium between the heterodimer and aggregated
forms of clusterin shifts in favor of the heterodimer, leading to enhanced exposure of
these hydrophobic surfaces which are then available for binding to target proteins. The
finding that these effects occur at mildly acidic pH suggests that they may be linked to
protonation of histidine residues. A comparison of the sequences of clusterin from eight
different mammals shows that there are five highly conserved histidine residues within
residues 241 and 290 of the protein (human clusterin numbering). Thus, H252 and H263
are found in all of the available sequences while H290, H241 and H261 are also highly
conserved, being found in a minimum of five of the eight sequences. It is therefore
possible that this region of clusterin represents an “electrostatic switch”; pH-dependent
protonation of its histidine residues may lead to disruption of the interfaces between
heterodimers within clusterin aggregates, favoring dissociation of the aggregates.

A possible mechanism for the chaperone action of clusterin is schematically represented
in Figure 8. This scheme is analogous to that proposed for the sHSPs (25) and draws on
the conclusions of recent work demonstrating that clusterin binds preferentially to slowly
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aggregating proteins on the off-folding pathway (11). The unfolding of a target protein
under stress conditions occurs via a series of partly structured intermediates or molten
globule states that are present along the normal protein folding pathway. These
intermediates are relatively long-lived and potentially unstable because they expose
significant hydrophobicity to solution which may facilitate their aggregation and
precipitation via the irreversible off-folding pathway. A protein that is present on the offfolding pathway undergoes dynamic processes of association and dissociation. In
solution, clusterin also exhibits reversible association to form aggregates of various sizes
(14). According to our model, the chaperone-active form of clusterin is the 80 kDa
heterodimer. The proportion of clusterin present in solution in this form at pH 6 is about
3 fold greater than that present at pH 7.5 (estimated by deconvolution analysis of the
areas under the size exclusion chromatographic peaks shown in Figure 4 in (14)).
Consistent with our model, this increase is comparable in magnitude to the corresponding
pH-dependent increases measured for (i) the binding of clusterin to stressed
ovotransferrin, GST and BSA in ELISA (2.4, 2.2 and 3.5 fold enhanced binding,
respectively, estimated from the change in absorbance measured at a clusterin
concentration of 5 µg/ml, see Figures 5A-C), and (ii) clusterin-mediated inhibition of
heat-stressed ovotransferrin (2.9 fold reduced precipitation, estimated from the change in
absorbance at 30 min, see Figure 6A). The interaction of clusterin with a stressed protein
target during chaperone action may involve the target protein binding to the clusterin
heterodimer which is then incorporated into a highly aggregated complex of two proteins
(Figure 8). We have previously demonstrated that clusterin forms high molecular weight
complexes with stressed proteins (9). This proposed mechanism does not require major
conformational changes within the protein and thus an input of energy is unnecessary. It
is also consistent with the lack of effect of ATP on the chaperone action of clusterin (10).
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The extent to which clusterin undergoes pH-dependent structural and functional changes
in vivo is an important question that remains to be completely addressed. Owing to the
known associations of clusterin in plasma with high density lipoprotein particles and
apoA-I (31), and IgG (16), and the enhanced interaction of clusterin with apoA-I and IgG
in serum at mildly acidic pH (14), it is very difficult to assess the extent to which
clusterin exhibits pH-dependent changes in its aggregation state in vivo. However, three
pieces of evidence support the hypothesis that clusterin undergoes pH-dependent
functional changes in vivo:
(i)

Clusterin purified from serum at pH 6 is associated with 4-6 times as much of its
native protein ligands, apoA-I and IgG, than clusterin purified at pH 7.4 (14).

(ii)

The binding of clusterin in serum to stressed proteins is enhanced at mildly acidic
pH (Figure 5D).

(iii)

Mildly acidic pH also enhances the ability of clusterin in serum to inhibit the heatinduced precipitation of serum proteins (Figure 6A).

The enhanced ligand-binding and chaperone actions of clusterin at low pH may have
important physiological relevance. A phenomenon known as local acidosis occurs at sites
of tissue damage or inflammation where the local pH falls to pH < 6. This phenomenon
has been reported to occur at sites of inflammation (32), cardiac ischaemia (33), infarcted
brain (34), and in the brains of Alzheimer’s sufferers (35). Under these conditions,
clusterin oligomers may dissociate and the enhanced binding/chaperone actions of the 80
kDa species could help to inhibit the aggregation and deposition of inflammatory and/or
toxic insoluble protein deposits which would otherwise exacerbate pathology.
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FIGURE LEGENDS

Figure 1 Temperature-dependence of the far-UV CD spectrum of clusterin and
solvent-exposed clusterin hydrophobicity. (A) Far-UV CD. The percentages of αhelical (n), β-sheet (l), β-turn (6) and disordered secondary structure (5) in clusterin
were calculated from data acquired as described in Experimental Procedures. The
corresponding open symbols at 25 ºC represent the calculated secondary structural
elements in clusterin after cooling from 85 ºC to 25 ºC. (B) bisANS fluorescence. Samples
of 10 µM bisANS in PBS containing 100 µg/ml clusterin (n,o) and 10 µM bisANS in
40% (v/v) ethanol (l,O) were progressively heated to the indicated temperatures between
20 and 50 ºC (heating cycle). The samples was held at each temperature for 1-2 min and
their bisANS fluorescence (closed symbols) measured as in Experimental Procedures.
During the subsequent cooling cycle, the samples were progressively cooled back to 20
ºC and were held for 1-2 min at the indicated temperatures while their bisANS
fluorescence (open symbols) was measured. The data for both samples have been
normalized to their 20 ºC fluorescence at the start of the heating cycle and are means ±
standard deviations of five measurements; in most cases the error bars are smaller than
the data symbols and in some cases the data symbols at particular temperatures in the
heating and cooling cycles overlap.

Figure 2 Effects of temperature on the binding of clusterin to stressed BSA in
ELISA. Reductively stressed BSA was adsorbed to ELISA plates and subsequently
incubated with clusterin at the temperatures indicated in the key. Bound clusterin was
detected as described in Experimental Procedures. Individual data points are the mean of

26

triplicate measurements. In each case, the error bars shown represent standard deviations
of the mean and in many cases are too small to be visible. The binding of clusterin to
unstressed BSA in ELISA was negligible (data not shown; see (9)). The results shown are
representative of two independent experiments.

Figure 3 Effects of temperature on the in vitro chaperone action of clusterin. BSA
was stressed by reduction with DTT as described in Experimental Procedures and protein
precipitation at either 37 oC (circular symbols) or 50 oC (square symbols) measured as
absorbance at 360 nm as a function of time. These experiments were performed either in
the absence of clusterin (empty symbols) or in the presence of clusterin (solid symbols)
(see key). Each experiment was performed a minimum of three times and the individual
traces shown are representative.

Figure 4 pH dependence of the near-UV CD spectrum of clusterin. Near-UV spectra
of clusterin in 20 mM sodium phosphate, pH 7.4 (dashed line) or in 20 mM MES, pH 5.5
(solid line) were obtained as described in Experimental Procedures. The data shown are
means of three scans.

Figure 5 Plots showing results from ELISA measuring the concentration-dependent
binding of clusterin to stressed proteins at different pH values (indicated in the key).
Stressed proteins tested were heat-stressed (A) ovotransferrin (ovo) and (B, D) GST, and
reduced (C) BSA. Clusterin was provided either as a purified protein (A-C) or in
unfractionated human serum (D), as described in Experimental Procedures. Data points
shown represent means of triplicate measurements. In each case, the error bars shown
represent standard deviations of the mean and in many cases are too small to be visible.
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The binding of clusterin to unstressed proteins in ELISA was negligible (data not shown;
see (9)).

Figure 6 Effects of mildly acidic pH on the in vitro chaperone action of clusterin and
-crystallin. (A) Mildly acidic pH enhances the chaperone action of clusterin.
Ovotransferrin (ovo) or unfractionated human serum (diluted 1 in 10) were stressed as
described in Experimental Procedures and protein precipitation at pH 7.5 (triangular
symbols), 6.5 (square symbols) or 6.0 (diamond symbols) measured as absorbance at 360
nm as a function of time. These experiments were performed either in the absence of
clusterin (empty symbols) or in the presence of clusterin (solid symbols) (see key).
Clusterin-depleted serum (CDS) was prepared from normal human serum (NHS) by
immunoaffinity chromatography, as described in Experimental Procedures. (B) Mildly
acidic pH inhibits the chaperone action of -crystallin. The same type of experiment was
performed, using ovotransferrin as the stressed protein target, in the absence (empty
symbols) or presence of α-crystallin (solid symbols). The different pH values tested are
represented by the same symbols as in (A), pH 7.0 is represented by circles. For clarity,
results in the absence of α-crystallin at pH 6.5 and 7.0 are not shown. Each experiment
was performed a minimum of three times and the individual traces shown are
representative.

Figure 7

Effects of bisANS on the interaction between clusterin and stressed

proteins. (A) bisANS inhibits the binding of clusterin to stressed proteins in ELISA. The
binding of clusterin (10 µg/ml in PBSMESBSA) to stressed lysozyme (lys), insulin and
alcohol dehydrogenase (ADH) in the presence of the indicated concentrations of bisANS
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was measured as described in Experimental Procedures. The binding of clusterin to the
stressed proteins (l) and to the BSA blocker only (o) is shown. The data shown are
means ± standard deviations of triplicate determinations. In many cases, the error bars are
too small to be visible. (B) Photochemical cross-linking of bisANS to clusterin reduces
the ability of clusterin to inhibit stressed protein precipitation. Solutions containing GST
alone (o) or GST and either unmodified clusterin (l) or bisANS-modified clusterin (o)
were heated at 60 oC and protein precipitation measured as described in Experimental
Procedures. The data shown are representative of two independent experiments.

Figure 8 A schematic representation of a possible mechanism for the chaperone
action of clusterin. Under conditions of stress, in this case decreased pH, a native protein
will start to unfold and adopt a series of partly folded intermediate states (eg I1 and I2).
The I1 state has more residual structure than I2. These intermediates, particularly I2,
expose significant hydrophobicity to solution and are relatively long lived compared to
the transient intermediates that are found on the relatively rapid protein folding pathway.
As a result, I2 may aggregate and enter the slow off-folding pathway that can potentially
lead to irreversible aggregation. Along this pathway, the chaperone-active heterodimeric
form of clusterin interacts and binds to I2 which is then sequestered into a large clusterinI2 complex. The concentration of heterodimeric clusterin is enhanced at acidic pH due to
a shift in the equilibrium from the polymeric form and is an important factor influencing
the efficiency of clusterin chaperone action. The mechanism requires no input of energy.
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